A maker of the widely used abortion pill mifepristone asked the Supreme Court to block an appellate court ruling that cut off mail-order access to the drug in what was the biggest jolt to abortion policy since the overturning of Roe v. Wade. (AP video produced: Joseph B. Frederick) Boxes of the drug mifepristone sit on a shelf at the West Alabama Women’s Center in Tuscaloosa, Ala., March 16, 2022. (AP Photo/Allen G.
Main Idea: The Supreme Court temporarily kept abortion pill mifepristone available while it weighs whether to let new limits backed by Louisiana take effect.
Key Points:
Louisiana’s push to limit mifepristone could reduce mail and pharmacy access, forcing some patients to travel farther, wait longer, or face higher costs for abortion care.
The Supreme Court’s pause keeps current access in place for now, letting patients and clinics keep using a common medicine while the case is still unsettled.
Rate how each entity in this article affected the American people.
Named justice whose emergency order is a key action in the article.
Central institution in the story; it temporarily extended access to mifepristone while considering restrictions.
The appellate court whose ruling would suspend mail-order and telehealth access is central to the story.
Federal agency whose mifepristone rules are being challenged and are central to the case.
His administration’s silence and political position are part of the article’s central conflict.
Group cited as weighing in against restrictions on the drug.
Named justice referenced for his prior dissent in the earlier mifepristone case.
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to commentOrganized advocacy and professional groups cited as cautioning the court against limiting access.
The drug’s manufacturer is a key party asking the court to block the appellate ruling, though not named.
Broad commercial actor cited as warning that restrictions would disrupt the drug approval process.
Major legal precedent referenced as background for the abortion policy conflict, but not an actor.